// App-Quantinova.ai

1308 : Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer

Researchers

Presenter

  • Wen-Pin Su

Principal Investigators

  • Jang-Yang Chang

  • Ching-Chuan Kuo

  • Wu-Chou Su

Medical Centers

  • Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  • Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  • Institute of Biotechnology & Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Tuberculosis

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Proto-oncogene tyrosine-protein kinase ROS

  • Sequestosome-1

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Everolimus

  • Rapacan

  • genipin

  • BGT226

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved